← Company Directory
Morphic Therapeutic
Work Here? Claim Your Company
Top Insights
  • Contribute something unique about Morphic Therapeutic that may be helpful for others (ex. interview tips, choosing teams, unique culture, etc).

  • About

    Morphic Holding is a biopharmaceutical company that develops oral small-molecule integrin therapeutics for autoimmune, cardiovascular, metabolic diseases, fibrosis, and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor in Phase 1 clinical trial for inflammatory bowel disease, and avß6 for fibrotic diseases. The company has collaborations with Engitix, Schrödinger, AbbVie Biotechnology, and Janssen Pharmaceuticals. Morphic Holding was founded in 2014 and is based in Waltham, Massachusetts.

    Year Founded
    # of Employees
    Estimated Revenue

    Get Verified Salaries in your Inbox

    Subscribe to verified offers. You’ll get the breakdown of compensation details by email. Learn More →

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Featured Jobs

      No featured jobs found for Morphic Therapeutic

    Related Companies

    • Spotify
    • Facebook
    • Pinterest
    • Dropbox
    • DoorDash
    • See all companies ➜